Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyasu Taniguchi

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Cancer Science|January 6, 2011
Secondary mutations of BRCA1/2 and drug resistanceKiranjit K Dhillon, Elizabeth M Swisher, Toshiyasu Taniguchi
Genes & Development|August 18, 2004
ATR couples FANCD2 monoubiquitination to the DNA-damage responsePaul R Andreassen, Alan D D'Andrea, Toshiyasu Taniguchi
Cell Cycle (Georgetown, Tex.)|November 29, 2016
NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protectionAntonio Abeyta, Maria Castella, Celine Jacquemont, et al.
Life Science Alliance|July 29, 2022
RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage toleranceRie Kanao, Hidehiko Kawai, Toshiyasu Taniguchi, et al.
Molecular Cancer|April 28, 2012
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatinCéline Jacquemont, Julian A Simon, Alan D D'Andrea, et al.
Endocrine-Related Cancer|August 17, 2016
Synthetic lethality: the road to novel therapies for breast cancerKiranjit K Dhillon, Ilirjana Bajrami, Toshiyasu Taniguchi, et al.
Molecular and Cellular Biology|September 1, 2006
Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistanceGary P H Ho, Steven Margossian, Toshiyasu Taniguchi, et al.
Cancer Research|April 26, 2014
p53 is positively regulated by miR-542-3pYemin Wang, Jen-Wei Huang, Maria Castella, et al.
Cancer Research|July 5, 2012
MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibitionYemin Wang, Jen-Wei Huang, Philamer Calses, et al.
Scientific Reports|February 3, 2026
DGCR8 regulates multiple processes of transcription coupled nucleotide excision repairTakaaki Watanabe, Daiyu Yoshinami, Hiroyuki Yamasaki, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Cancer Science|January 6, 2011
Secondary mutations of BRCA1/2 and drug resistanceKiranjit K Dhillon, Elizabeth M Swisher, Toshiyasu Taniguchi
Genes & Development|August 18, 2004
ATR couples FANCD2 monoubiquitination to the DNA-damage responsePaul R Andreassen, Alan D D'Andrea, Toshiyasu Taniguchi
Cell Cycle (Georgetown, Tex.)|November 29, 2016
NEK8 regulates DNA damage-induced RAD51 foci formation and replication fork protectionAntonio Abeyta, Maria Castella, Celine Jacquemont, et al.
Life Science Alliance|July 29, 2022
RFWD3 and translesion DNA polymerases contribute to PCNA modification-dependent DNA damage toleranceRie Kanao, Hidehiko Kawai, Toshiyasu Taniguchi, et al.
Molecular Cancer|April 28, 2012
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatinCéline Jacquemont, Julian A Simon, Alan D D'Andrea, et al.
Endocrine-Related Cancer|August 17, 2016
Synthetic lethality: the road to novel therapies for breast cancerKiranjit K Dhillon, Ilirjana Bajrami, Toshiyasu Taniguchi, et al.
Molecular and Cellular Biology|September 1, 2006
Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistanceGary P H Ho, Steven Margossian, Toshiyasu Taniguchi, et al.
Cancer Research|April 26, 2014
p53 is positively regulated by miR-542-3pYemin Wang, Jen-Wei Huang, Maria Castella, et al.
Cancer Research|July 5, 2012
MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibitionYemin Wang, Jen-Wei Huang, Philamer Calses, et al.
Scientific Reports|February 3, 2026
DGCR8 regulates multiple processes of transcription coupled nucleotide excision repairTakaaki Watanabe, Daiyu Yoshinami, Hiroyuki Yamasaki, et al.
Pageof 6